SAN DIEGO and BETHESDA, Md. — Organovo announced today that they are joining together with two institutes from the National Institutes of Health (NIH) to help scientists develop more reliable tools for bringing safer, more effective treatments to patients on a faster timeline. Organovo is collaborating with the National Center for Advancing Translational Sciences (NCATS) […]
Leiden, the Netherlands – MIMETAS and Galapagos (Euronext: GLPG) have entered into a research collaboration on the development of organ-on-a-chip-based human disease models for new medicine development. The companies will collaborate to develop miniaturized 3D cell culture models that mimic specific aspects of human diseases. These models will be applied to the identification and improvement […]
Halifax, Nova Scotia – MedMira Inc., (MedMira) (TSXV: MIR), a developer of rapid testing technologies and solutions, today announced a U.S. distribution agreement with VWR International LLC, a global solutions provider of laboratory supplies and services with worldwide sales in excess of $4.1 billion in 2012. Through this new agreement, MedMira will benefit from the […]
End of December 2013 Biognosys has secured USD 1 million financing in form of a convertible loan. This financing will ensure future growth of the company by expanding its commercial operations and product development. In addition, Biognosys strengthened the existing management team by appointing Russell Golson as Director of Sales and Dr. Lukas Reiter as […]
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced the launch of its 2014 global research grant program, open to researchers from academic and non-profit institutions. “Exiqon aims to support our customers around the world in their everyday laboratory work and we are proud to offer excellent products for the analysis of any RNA in any […]
Eurofins Scientific (EUFI.PA), the world leader in providing analytical support to the pharmaceutical industry, announces the signing of an agreement to acquire the assets of the Discovery and Development Solutions (DDS) business of Merck Millipore (EMD Millipore in the United States and Canada), the Life Science division of Merck KGaA, Darmstadt, Germany. DDS is a […]
MADISON, WIS. – Cellular Dynamics International (CDI; Nasdaq: ICEL) today announced signing a long-term supply agreement with the Nestlé Institute of Health Sciences SA (NIHS).Terms of the agreement were not disclosed. CDI’s iCell® product line includes cardiomyocytes, neurons, hepatocytes, and endothelial cells, with numerous other cell types in development. The company’s MyCell® Products are cell […]
Paris – Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced the completion of a structurally important transaction concerning its subsidiary Cellectis bioresearch, which specializes in designing, developing and marketing products and services essentially for academic and biopharmaceutical industry researchers: a simplified legal structure, with Ectycell merged into Cellectis bioresearch; and a reinforced equity position, […]
Manassas, VA — Biomatrica®, Inc., a world leader in ambient temperature biological stabilization technologies, and ATCC, the premier global biological materials resource and standards organization, today announce the completion of a licensing agreement. According to the agreement terms, Biomatrica will supply ATCC with DNAstable® and RNAstable® reagents for the stabilization of DNA and RNA standards. […]
FREMONT, Calif. — WaferGen Bio-systems, Inc. (QTCQB: WGBS) announced today the acquisition of the NGS library preparation business from IntegenX Inc. Pursuant to the asset purchase agreement, WaferGen Bio-systems, Inc., through Wafergen, Inc., its wholly owned subsidiary, acquired on January 6, 2014 substantially all of the assets of IntegenX’s product line used in connection with […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
